Atherosclerosis is an inflammatory disease that involves antibody immune responses. Progression of hyperlipidemia can lead to atherosclerosis and subsequently cardiovascular diseases with high mortality. Additional lipid-lowering therapies other than statins are currently being studied, such as monoclonal antibodies. In this contemporary review, we examine the various monoclonal antibody therapies targeted toward atherosclerotic disease.
|Original language||English (US)|
|Journal||Current Problems in Cardiology|
|State||Published - Apr 2023|
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine